Thu Sep 19 08:18:20 UTC 2024: ## AdaptHealth Sees Increased Institutional Investment: Rhumbline Advisers Boosts Stake

**New York, NY – September 19, 2024** – Rhumbline Advisers, a prominent institutional investor, increased its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 1.3% during the second quarter, according to a recent SEC filing. The firm now owns 271,033 shares, representing approximately 0.20% of AdaptHealth, valued at $2,710,000.

This move follows a trend of increased institutional interest in AdaptHealth. Other notable investors, including Vanguard Group Inc., Peregrine Capital Management LLC, Hillsdale Investment Management Inc., and Tocqueville Asset Management L.P., have also boosted their positions in the company in recent quarters. Overall, institutional investors and hedge funds now own 82.67% of AdaptHealth’s outstanding shares.

AdaptHealth shares opened at $11.33 on Thursday. The company’s stock has a market cap of $1.51 billion and a PE ratio of -2.15.

**Insider Trading and Analyst Sentiment**

AdaptHealth Director David Solomon Williams III sold 4,000 shares of the company’s stock on August 29th for a total value of $45,040.00. Meanwhile, Royal Bank of Canada reiterated an “outperform” rating and issued a $13.00 price objective on AdaptHealth shares in a research report on August 12th. Other analysts have assigned a “hold” or “buy” rating to the company, with an overall consensus rating of “Hold” and a consensus target price of $10.70.

**AdaptHealth’s Business**

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides a wide range of products and services, including sleep therapy equipment, medical devices, and oxygen therapy, catering to chronically ill patients.

Read More